A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)

NCT07742735 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Short Bowel Syndrome (SBS)
SBS Associated With Intestinal Failure (SBS-IF)

Interventions

DRUG: Apraglutide
DRUG: Placebo

Sponsor

VectivBio AG

Collaborators

[object Object]